Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Generate Biomedicines, Inc.(GENB) | 62,673,117 | 62,673,117 | 0 | $1.06B | $941.35M | 48.14% | -$115.95M |
| Moderna, Inc.(MRNA) | 4,632,149 | 4,632,149 | 0 | $324.39M | $892.01M | 45.62% | +$567.62M |
| Sana Biotechnology Inc | 25,001,856 | 25,001,856 | 0 | $87.26M | $72.88M | 3.73% | -$14.38M |
| Foghorn Therapeutics Inc | 12,674,120 | 12,674,120 | 0 | $61.85M | $45.25M | 2.31% | -$16.60M |
| Seres Therapeutics Inc | 1,155,850 | 1,155,850 | 0 | $9.12M | $3.87M | 0.20% | -$5.25M |